8-K: Trulieve Cannabis Corp. Reports Mixed Q3 2024 Results Amidst Florida Legalization Push

Trulieve Cannabis Corp. announced a 3% year-over-year revenue increase to $284 million for Q3 2024, alongside a net loss of $60 million, while heavily investing in Florida's adult-use cannabis campaign.

Summary

• Trulieve Cannabis Corp. reported a revenue of $284 million for the third quarter of 2024, a 3% increase compared to the same period last year.
• The company's gross margin improved to 61%, up from 52% in Q3 2023.
• However, Trulieve experienced a net loss of $60 million attributable to common shareholders.
• Adjusted net loss was $12 million, excluding $48 million in campaign support and other non-recurring charges.
• Adjusted EBITDA reached $96 million, representing 34% of revenue, a 24% increase year-over-year.
• Cash flow from operations was $30 million, and free cash flow was $(7) million, both impacted by the $48 million campaign support.
• The company ended the quarter with $319 million in cash and short-term investments.
• Trulieve launched adult-use sales in three Ohio locations and opened 15 new dispensaries in Florida and Pennsylvania.
• The company also supported the Smart and Safe Florida adult-use campaign with a #YesOn3 product line and $48 million in campaign support.
• Year-to-date cash flow from operations is $241 million and free cash flow is $162 million.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative due to the net loss and negative free cash flow, offset by positive revenue growth and improved gross margins. The large investment in the Florida campaign adds uncertainty.

Positives

• Revenue increased by 3% year-over-year to $284 million.
• Gross margin improved significantly to 61% from 52% in the same quarter last year.
• Adjusted EBITDA increased by 24% year-over-year to $96 million.
• The company has $319 million in cash and short-term investments.
• Trulieve expanded its retail footprint by opening 15 new dispensaries.
• The company launched adult-use sales in Ohio.
• Year-to-date cash flow from operations is $241 million and free cash flow is $162 million.

Negatives

• The company reported a net loss of $60 million attributable to common shareholders.
• Free cash flow was negative at $(7) million for the quarter, impacted by campaign spending.
• Operating expenses were $173 million, which is 61% of revenue.
• Net loss from continuing operations was $(60) million.
• The company spent $48 million on campaign support for Florida's adult-use cannabis initiative.

Risks

• The company's financial results are heavily influenced by the outcome of the Florida adult-use cannabis vote.
• The company faces risks related to regulatory approvals and changes in cannabis laws.
• There is uncertainty regarding the company's tax liability and refunds under Section 280E of the US tax code.
• The company is subject to competition from other cannabis companies.
• The company's cash flow was significantly impacted by the $48 million spent on the Florida campaign.

Future Outlook

The company anticipates fourth-quarter revenue will be up low single digits compared to the third quarter and expects gross margin to be comparable to year-to-date gross margin. They expect 2024 cash flow from operations to be at least $250 million and capital expenditures to be approximately $130 million.

Management Comments

• Kim Rivers, Trulieve CEO, stated that the company is best positioned to prepare for the launch of recreational sales next Spring if Florida approves cannabis legalization for personal use.
• Management believes that without the effect of 280E, year to date net income would have been positive.

Industry Context

The announcement comes as the cannabis industry is closely watching the Florida adult-use vote, which could significantly impact Trulieve's future growth. The company's expansion into Ohio also reflects the broader trend of cannabis legalization and market expansion across the US.

Comparison to Industry Standards

• Trulieve's gross margin of 61% is strong compared to some multi-state operators (MSOs) in the cannabis industry, such as Curaleaf and Green Thumb Industries, which have reported gross margins in the 50-60% range in recent quarters.
• However, Trulieve's net loss of $60 million is a concern, as some competitors have achieved profitability or smaller losses. For example, Green Thumb Industries has reported positive net income in recent quarters.
• The $48 million spent on the Florida campaign is a significant investment, and its impact on future revenue will be closely watched. Other MSOs have also invested in lobbying and marketing efforts, but the scale of Trulieve's investment is notable.
• Trulieve's adjusted EBITDA margin of 34% is competitive with other leading MSOs, indicating strong operational efficiency despite the net loss.
• The company's expansion into Ohio is similar to other MSOs that are expanding into new markets as they become legalized.

Stakeholder Impact

• Shareholders are impacted by the net loss, but may be encouraged by the revenue growth and improved gross margins.
• Employees may be impacted by the company's expansion and potential growth in new markets.
• Customers will benefit from the expansion of retail locations and product offerings.
• Suppliers may see increased demand for their products as the company expands.
• Creditors will be interested in the company's cash flow and debt levels.

Next Steps

• The company will host a conference call on November 5, 2024, to discuss the results.
• The company's Form 10-Q for the quarter ended September 30, 2024, will be available on the SEC's website.
• The company will continue to monitor the Florida adult-use vote and prepare for potential recreational sales next Spring.
• The company will continue to invest in cornerstone markets and expand its retail and wholesale distribution networks.

Key Dates

Keywords

cannabis, Trulieve, financial results, Q3 2024, adult-use, Florida, EBITDA, revenue, dispensaries, retail, cash flow, gross margin